<DOC>
	<DOCNO>NCT02677818</DOCNO>
	<brief_summary>The purpose study determine whether Plasma Factor VIII Levels relate treatment bleed ischemic stroke（IS） .</brief_summary>
	<brief_title>The Relationship Between Clotting Factor VIII Bleeding Adverse Reactions Patients Under Therapies Thrombolysis , Anticoagulation Anti-platelet</brief_title>
	<detailed_description>Clear cerebral infarction patient hospitalization , treatment process , discharge hemorrhage occur , stage F VIII level change correlation bleed adverse reaction . Analysis F VIII whether belong hemorrhage occur independent risk factor adverse drug reaction , well feasibility predict bleeding occur adverse reaction index .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Guidelines prepare diagnostic criterion ( accord diagnostic criterion Fourth National Stroke Conference prepare , one time skull CT and/or MRI ) confirm ischemic stroke , require use antithrombotic therapy ( include thrombolysis , anticoagulation , antiplatelet ) patient Willing able comply study protocol visit plan At time presence active malignancy . There know brain metastasis leptomeningeal metastasis Systemic active infection ( ie infection lead body temperature ≥38 ℃ ) The last 4 week need drainage ascites , pleural effusion pericardial fluid . Clinically significant obstruction , pulmonary fibrosis , kidney failure , liver failure disease . Uncontrolled diabetes . Severe / unstable angina , New York Heart Association ( NYHA ) class III IV symptom congestive heart failure reason ( antithrombotic drug ) cause bleeding . The presence autoimmune disease history organ transplant patient require immunosuppressive therapy Psychiatric presence may increase risk associate study participation study drug , may interfere interpretation study result Pregnant lactate woman Bleeding disorder may exist admission The researcher add study appropriate circumstance</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Plasma Factor VIII Levels</keyword>
	<keyword>Ischemic stroke</keyword>
	<keyword>Antithrombotic therapy</keyword>
	<keyword>Bleeding</keyword>
</DOC>